Oyster Point Pharma, Inc.
(NASDAQ GS: OYST)
Rigrodsky Law, P.A. is investigating Oyster Point Pharma, Inc. (“Oyster”) regarding possible breaches of fiduciary duties and other violations of law related to Oyster’s agreement to be acquired by Viatris Inc. Under the terms of the agreement, Oyster’s shareholders will receive $11.00 per share and a contingent value right for a potential cash payment of up to $2.00 per share.